Waning Humoral Immune Response Following the Third and Fourth SARS‐COV‐2 Vaccine: A Cohort Study in Healthcare Workers
Influenza and Other Respiratory Viruses · 2024
DOI: 10.1111/irv.70003 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Influenza and Other Respiratory Viruses, 2024. Verfasst von Ahmet Furkan Süner und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey. Hauptthemen laut MEDLINE: Health Personnel, Antibodies, Viral, COVID-19, COVID-19 Vaccines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dokuz Eylul University Department of Scientific Research Projects.
Abstract (Originalsprache)
Background
This study is aimed at providing information about the timing of booster doses and antibody kinetics in healthcare workers.
Methods
This research extends a prospective cohort study conducted at Dokuz Eylul University Hospital in Turkey, covering the period from March 2021 to December 2021. During this timeframe, the antibody levels of the health workers were measured at four different time points. The associations of antibody levels with gender, age, occupation, body mass index (BMI), chronic disease, and smoking were analyzed.
Results
There was a significant difference between antibody levels in all four blood draws ( p < 0.001). Antibody levels decreased in both those vaccinated with BNT162b2 ( p < 0.001) and those vaccinated with CoronaVac ( p = 0.002) until the fourth blood draw. There was a significant difference between those vaccinated with one and two doses of booster BNT162b2 before the third blood draw ( p < 0.001), which continued at the fourth blood draw ( p < 0.001). The antibody levels of those with an interval of 41–50 days between two vaccinations decreased significantly at the fourth blood draw ( p < 0.001).
Conclusions
This study provides insight into the dynamics and persistence of antibody response after additional COVID‐19 vaccine doses among healthcare workers. The longer the interval between booster doses may result in greater antibody levels being maintained over time, allowing for longer durations of protection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Public Health, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey.
- Infectious Diseases Unit, Diyarbakır Provincial Health Directorate, Diyarbakir, Turkey.
- Medical Microbiology Unit, Mardin Nusaybin State Hospital, Mardin, Turkey.
- Infectious Diseases and Clinical Microbiology Unit, Hakkari Yüksekova State Hospital, Hakkari, Turkey.
- Department of Medical Microbiology, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey.
- Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey.
ORCID-Profile: Ahmet Furkan Süner
Förderung
- Dokuz Eylul University Department of Scientific Research Projects
Zitieren
APA
Süner, A. F., Ergör, G., Çağlayan, D., Türe, N., Güzel, I., Irmak, Ç., Işık, E., Appak, Ö., Çelik, M., Öztürk, G., Çavuş, S. A., Sayiner, A., Ergör, A., Demiral, Y., & Kilic, B. (2024). Waning Humoral Immune Response Following the Third and Fourth SARS‐COV‐2 Vaccine: A Cohort Study in Healthcare Workers. Influenza and Other Respiratory Viruses. https://doi.org/10.1111/irv.70003
Vancouver
Süner AF, Ergör G, Çağlayan D, Türe N, Güzel I, Irmak Ç, et al. Waning Humoral Immune Response Following the Third and Fourth SARS‐COV‐2 Vaccine: A Cohort Study in Healthcare Workers. Influenza and Other Respiratory Viruses. 2024. doi:10.1111/irv.70003
BibTeX
@article{Sner2024,
author = {Süner, Ahmet Furkan and Ergör, Gül and Çağlayan, Derya and Türe, Neslişah and Güzel, Irmak and Irmak, Çağlar and Işık, Elif and Appak, Özgür and Çelik, Muammer and Öztürk, Gamze and Çavuş, Sema Alp and Sayiner, Arzu and Ergör, Alp and Demiral, Yücel and Kilic, Bulent},
title = {Waning Humoral Immune Response Following the Third and Fourth SARS‐COV‐2 Vaccine: A Cohort Study in Healthcare Workers},
journal = {Influenza and Other Respiratory Viruses},
year = {2024},
doi = {10.1111/irv.70003}
}
EUVIMED